Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level.

On July 11, 2024, Affluent Medical reached a major milestone with the signature of several agreements with Edwards Lifesciences, a global MedTech player, recognizing the relevance and potential of the ...